keyword
https://read.qxmd.com/read/38686692/depression-is-a-core-symptom-of-multiple-sclerosis-yes
#41
JOURNAL ARTICLE
Laura M Hancock
No abstract text is available yet for this article.
April 30, 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38686685/depression-is-a-core-symptom-of-multiple-sclerosis-no
#42
JOURNAL ARTICLE
Victoria M Leavitt
No abstract text is available yet for this article.
April 30, 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38686337/explainable-machine-learning-for-predicting-conversion-to-neurological-disease-results-from-52-939-medical-records
#43
JOURNAL ARTICLE
Christina Felix, Joshua D Johnston, Kelsey Owen, Emil Shirima, Sidney R Hinds, Kenneth D Mandl, Alex Milinovich, Jay L Alberts
OBJECTIVE: This study assesses the application of interpretable machine learning modeling using electronic medical record data for the prediction of conversion to neurological disease. METHODS: A retrospective dataset of Cleveland Clinic patients diagnosed with Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis, or Parkinson's disease, and matched controls based on age, sex, race, and ethnicity was compiled. Individualized risk prediction models were created using eXtreme Gradient Boosting for each neurological disease at four timepoints in patient history...
2024: Digital Health
https://read.qxmd.com/read/38684843/cognitive-profile-in-multiple-sclerosis-and-post-covid-condition-a-comparative-study-using-a-unified-taxonomy
#44
COMPARATIVE STUDY
Cristina Delgado-Alonso, Alfonso Delgado-Alvarez, María Díez-Cirarda, Silvia Oliver-Mas, Constanza Cuevas, Paloma Montero-Escribano, Ana Maria Ramos-Leví, María José Gil-Moreno, Juan Ignacio López-Carbonero, Bruce P Hermann, Jorge Matias-Guiu, Jordi A Matias-Guiu
Post-COVID condition (PCC) and multiple sclerosis (MS) share some clinical and demographic features, including cognitive symptoms and fatigue. Some pathophysiological mechanisms well-known in MS, such as autoimmunity, neuroinflammation and myelin damage, have also been implicated in PCC. In this study, we aimed to compare the cognitive phenotypes of two large cohorts of patients with PCC and MS, and to evaluate the relationship between fatigue and cognitive performance. Cross-sectional study including 218 patients with PCC and 218 with MS matched by age, sex, and years of education...
April 29, 2024: Scientific Reports
https://read.qxmd.com/read/38684744/a-novel-imaging-marker-of-cortical-cellularity-in-multiple-sclerosis-patients
#45
JOURNAL ARTICLE
Muhamed Barakovic, Matthias Weigel, Alessandro Cagol, Sabine Schaedelin, Riccardo Galbusera, Po-Jui Lu, Xinjie Chen, Lester Melie-Garcia, Mario Ocampo-Pineda, Erik Bahn, Christine Stadelmann, Marco Palombo, Ludwig Kappos, Jens Kuhle, Stefano Magon, Cristina Granziera
Pathological data showed focal inflammation and regions of diffuse neuronal loss in the cortex of people with multiple sclerosis (MS). In this work, we applied a novel model ("soma and neurite density imaging (SANDI)") to multishell diffusion-weighted MRI data acquired in healthy subjects and people with multiple sclerosis (pwMS), in order to investigate inflammation and degeneration-related changes in the cortical tissue of pwMS. We aimed to (i) establish whether SANDI is applicable in vivo clinical data; (ii) investigate inflammatory and degenerative changes using SANDI soma fraction (fsoma )-a marker of cellularity-in both cortical lesions and in the normal-appearing-cortex and (iii) correlate SANDI fsoma with clinical and biological measures in pwMS...
April 29, 2024: Scientific Reports
https://read.qxmd.com/read/38684324/identification-and-validation-of-anti-protein-arginine-methyltransferase-5-prmt5-antibody-as-a-novel-biomarker-for-systemic-sclerosis-ssc
#46
JOURNAL ARTICLE
Minrui Liang, Lingbiao Wang, Xiaolong Tian, Kun Wang, Xiaoyi Zhu, Linlin Huang, Qing Li, Wenjing Ye, Chen Chen, Haihua Yang, Wanqing Wu, Xiangjun Chen, Xiaoxia Zhu, Yu Xue, Weiguo Wan, Yanling Wu, Liwei Lu, Jiucun Wang, Hejian Zou, Tianlei Ying, Feng Zhou
OBJECTIVES: In the complex panorama of autoimmune diseases, the characterisation of pivotal contributing autoantibodies that are involved in disease progression remains challenging. This study aimed to employ a global antibody profiling strategy to identify novel antibodies and investigate their association with systemic sclerosis (SSc). METHODS: We implemented this strategy by conducting immunoprecipitation (IP) following on-bead digestion with the sera of patients with SSc or healthy donors, using antigen pools derived from cell lysates...
April 29, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/38684085/gait-features-in-different-environments-contributing-to-participation-in-outdoor-activities-in-old-age-gaitage-protocol-for-an-observational-cross-sectional-study
#47
JOURNAL ARTICLE
Merja Rantakokko, Emmi Matikainen-Tervola, Eeva Aartolahti, Sanna Sihvonen, Julija Chichaeva, Taija Finni, Neil Cronin
BACKGROUND: The ability to walk is a key issue for independent old age. Optimizing older peoples' opportunities for an autonomous and active life and reducing health disparities requires a better understanding of how to support independent mobility in older people. With increasing age, changes in gait parameters such as step length and cadence are common and have been shown to increase the risk of mobility decline. However, gait assessments are typically based on laboratory measures, even though walking in a laboratory environment may be significantly different from walking in outdoor environments...
April 29, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38684013/unlocking-therapeutic-potential-the-role-of-theta-burst-stimulation-in-multiple-sclerosis-management
#48
JOURNAL ARTICLE
David F Lo, Meejan Palhang, Ahmed Gawash, Hasan Zia, Brandon J Goodwin, Keyur Patel, Christian P White
Objective: Current therapies for multiple sclerosis (MS) often have limited efficacy and side effects, necessitating alternative approaches. Noninvasive brain stimulation (NIBS), such as transcranial direct current stimulation and transcranial magnetic stimulation (TMS), offers potential solutions. Among NIBS techniques, theta burst stimulation (TBS) is notable for its ability to modulate cortical activity. The objective of this systematic review is to assess the impact of TBS on MS symptoms. Data Sources: The study conducted rigorous systematic searches in PubMed, Google Scholar, and Scopus databases up to June 2023, using specific Medical Subject Headings terms related to NIBS and MS, such as TMS and TBS, in conjunction with terms like MS or demyelinating disease...
April 18, 2024: Primary Care Companion to CNS Disorders
https://read.qxmd.com/read/38683493/pb006-a-natalizumab-biosimilar
#49
REVIEW
Matt Shirley
PB006 (Tyruko® ) is the first biosimilar of the reference monoclonal anti-α4-integrin antibody natalizumab. It is approved for use in the same indications for which reference natalizumab is approved, as a single disease-modifying therapy in adults with highly active relapsing-remitting multiple sclerosis (RRMS). PB006 has similar physicochemical and pharmacodynamic properties to those of reference natalizumab, and the pharmacokinetic similarity of the agents has been demonstrated in a study in healthy subjects...
April 29, 2024: Clinical Drug Investigation
https://read.qxmd.com/read/38683467/radiosynthesis-automation-non-human-primate-biodistribution-and-dosimetry-of-k-channel-tracer-11-c-3meo4ap
#50
JOURNAL ARTICLE
Yu-Peng Zhou, Moses Q Wilks, Maeva Dhaynaut, Nicolas J Guehl, Danielle R Vesper, Sung-Hyun Moon, Peter A Rice, Georges El Fakhri, Marc D Normandin, Pedro Brugarolas
BACKGROUND: 4-Aminopyridine (4AP) is a medication for the symptomatic treatment of multiple sclerosis. Several 4AP-based PET tracers have been developed for imaging demyelination. In preclinical studies, [11 C]3MeO4AP has shown promise due to its high brain permeability, high metabolic stability, high plasma availability, and high in vivo binding affinity. To prepare for the translation to human studies, we developed a cGMP-compatible automated radiosynthesis protocol and evaluated the whole-body biodistribution and radiation dosimetry of [11 C]3MeO4AP in non-human primates (NHPs)...
April 29, 2024: EJNMMI Research
https://read.qxmd.com/read/38682490/trp-channels-in-excitotoxicity
#51
REVIEW
Pengyu Zong, Nicholas Legere, Jianlin Feng, Lixia Yue
Glutamate excitotoxicity is a central mechanism contributing to cellular dysfunction and death in various neurological disorders and diseases, such as stroke, traumatic brain injury, epilepsy, schizophrenia, addiction, mood disorders, Huntington's disease, Alzheimer's disease, Parkinson's disease, multiple sclerosis, pathologic pain, and even normal aging-related changes. This detrimental effect emerges from glutamate binding to glutamate receptors, including α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, N -methyl-d-aspartate receptors, kainate receptors, and GluD receptors...
April 29, 2024: Neuroscientist: a Review Journal Bringing Neurobiology, Neurology and Psychiatry
https://read.qxmd.com/read/38682309/cutibacterium-acnes-derived-extracellular-vesicles-promote-tumor-growth-in-renal-cell-carcinoma
#52
JOURNAL ARTICLE
Kentaro Jingushi, Atsunari Kawashima, Sayaka Tanikawa, Takuro Saito, Akinaru Yamamoto, Toshihiro Uemura, Nesrine Sassi, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Hiroaki Hase, Norio Nonomura, Kazutake Tsujikawa
Bacterial flora are present in various parts of the human body, including the intestine, and are thought to be involved in the etiology of various diseases such as multiple sclerosis, intestinal diseases, cancer, and uterine diseases. In recent years, the presence of bacterial 16S rRNA genes has been revealed in blood, which was previously thought to be a sterile environment, and characteristic blood microbiomes have been detected in various diseases. However, the mechanism and the origin of the bacterial information are unknown...
April 29, 2024: Cancer Science
https://read.qxmd.com/read/38682229/immune-ataxias-the-continuum-of-latent-ataxia-primary-ataxia-and-clinical-ataxia
#53
REVIEW
Mario Manto, Hiroshi Mitoma
The clinical category of immune-mediated cerebellar ataxias (IMCAs) is now recognized after 3 decades of clinical and experimental research. The cerebellum gathers about 60% of neurons in the brain, is enriched in numerous plasticity mechanisms, and presents a large variety of antigens at the neuroglial level: ion channels and related proteins, synaptic adhesion/organizing proteins, transmitter receptors, and glial cells. Cerebellar circuitry is especially vulnerable to immune attacks. After the loss of immune tolerance, IMCAs present in an acute or subacute manner with various combinations of a vestibulocerebellar syndrome (VCS), a cerebellar motor syndrome (CMS), and a cerebellar cognitive affective syndrome/Schmahmann's syndrome (CCAS/SS)...
April 12, 2024: Journal of Integrative Neuroscience
https://read.qxmd.com/read/38682185/deciphering-the-enigma-of-neuron-glial-interactions-in-neurological-disorders
#54
REVIEW
S Rehan Ahmad, Md Zeyaullah, Abdullah M AlShahrani, Adam Dawria, Haroon Ali, Ali Mohieldin, Abdelrhman Ag Altijani, Ufaq Razi, Munzila Mehdi, Sabika Akram, Ejaz Rizvi Hussain
Innate lymphocytes, including microglial cells, astrocytes, and oligodendrocytes, play a crucial role in initiating neuroinflammatory reactions inside the central nervous system (CNS). The prime focus of this paper is on the involvement and interplay of neurons and glial cells in neurological disorders such as Alzheimer's Disease (AD), Autism Spectrum Disorder (ASD), epilepsy, and multiple sclerosis (MS). In this review, we explore the specific contributions of microglia and astrocytes and analyzes multiple pathways implicated in neuroinflammation and disturbances in excitatory and inhibitory processes...
April 8, 2024: Frontiers in Bioscience (Landmark Edition)
https://read.qxmd.com/read/38681666/the-role-of-neuroinflammation-in-neurodegenerative-diseases-current-understanding-and-future-therapeutic-targets
#55
REVIEW
Alhamdu Adamu, Shuo Li, Fankai Gao, Guofang Xue
Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen and nitrogen species are synthesized. Neuroinflammation is a key process that helps protect the brain from pathogens, but inappropriate, or protracted inflammation yields pathological states such as Parkinson's disease, Alzheimer's, Multiple Sclerosis, and other neurodegenerative disorders that showcase various pathways of neurodegeneration distributed in various parts of the CNS...
2024: Frontiers in Aging Neuroscience
https://read.qxmd.com/read/38681400/double-seronegative-neuromyelitis-optica-spectrum-disorder-with-longitudinally-extensive-transverse-myelitis-and-optic-neuritis-a-challenging-case-report
#56
Goh Chon Han, Tajunisah Iqbal, Gowri Supramaniam
Neuromyelitis optica spectrum disorder (NMOSD) is a rare antibody-mediated neuroinflammatory disease of the central nervous system, typically manifesting in the optic nerves, spinal cord, and other regions of the central nervous system. We hereby report a case of a 16-year-old girl who presented with a six-month history of transverse myelitis with an acute episode of bilateral retrobulbar optic neuritis. MRI revealed patchy contrast enhancements over bilateral retrobulbar intraorbital optic nerves together with long-segment spinal cord hyperintensities (C2 to T2 level)...
March 2024: Curēus
https://read.qxmd.com/read/38681390/the-prevalence-and-impact-of-urinary-incontinence-on-multiple-sclerosis-patients-in-taif-city-saudi-arabia
#57
JOURNAL ARTICLE
Adnan A Mubaraki, Matooqa A Alnemari, Sarah O Aljuaid, Fai M Altalhi, Yazan M Alamri, Shahad O Altowairqi
Introduction Multiple sclerosis (MS) is a chronic inflammatory disease that results in demyelination and progressive loss of nerve cells within the central nervous system. Multiple sclerosis, as well as other neurological diseases that impact brain structures and spinal pathways involved in sphincter control, may cause lower urinary tract symptoms (LUTS) Our aims are to determine the prevalence, severity, and impact on the quality of life of urinary incontinence among MS patients in Taif, Saudi Arabia, as well as its potential association with demographics and clinical features...
March 2024: Curēus
https://read.qxmd.com/read/38681355/fracture-or-not-an-easily-mistaken-benign-finding-in-a-tuberous-sclerosis-patient
#58
Sana Padival, Tyler P Montgomery, Alan E Oestreich, James Banks
Tuberous sclerosis (TSC) is a rare autosomal dominant disorder that can affect multiple organ systems, including the brain, heart, lungs, and skin. Cutaneous manifestations are common, including ungual fibromas, however, these may be mistaken for other pathologies. Here, we present the case of a 14-year-old with TSC complaining of traumatic left little finger pain. Radiographic evaluation revealed cortical scalloping of the nailbed, concerning for a non-displaced fracture. Given the history of TSC, however, this defect may have also represented a periungual fibroma...
March 2024: Curēus
https://read.qxmd.com/read/38681299/rehabilitation-outcomes-in-multiple-sclerosis-patients-on-ocrelizumab-diagnosed-with-west-nile-virus-encephalitis
#59
Taylor R Johnson, Stephanie Gandelman, Lauren R Serafin, Jeremy Y Charles, Dina Jacobs
Multiple sclerosis (MS) has a global prevalence exceeding two million people and is a leading cause of non-traumatic physical disability. MS can be treated with ocrelizumab, an anti-CD20 monoclonal antibody. West Nile virus (WNV) is the most common cause of mosquito-borne viral encephalitis in North America. It can lead to neuroinvasive WNV disease (WNND) affecting the brain and peripheral nervous system, especially in immunocompromised patients, such as those being treated with ocrelizumab for MS...
March 2024: Curēus
https://read.qxmd.com/read/38681197/phytochemicals-derived-from-nicotiana-tabacum-l-plant-contribute-to-pharmaceutical-development
#60
REVIEW
Wenji Zhang, Xiaoying Pan, Jiaqi Fu, Wenli Cheng, Hui Lin, Wenjuan Zhang, Zhenrui Huang
The Nicotiana tabacum L. plant, a medicinal resource, holds significant potential for benefiting human health, as evidenced by its use in Native American and ancient Chinese cultures. Modern medical and pharmaceutical studies have investigated that the abundant and distinctive function metabolites in tobacco including nicotine, solanesol, cembranoid diterpenes, essential oil, seed oil and other tobacco extracts, avoiding the toxic components of smoke, mainly have the anti-oxidation, anti-lipid production, pro-lipid oxidation, pro-insulin sensitivity, anti-inflammation, anti-apoptosis and antimicrobial activities...
2024: Frontiers in Pharmacology
keyword
keyword
109647
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.